Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair.
about
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shockRole of diabetes in the development of acute respiratory distress syndrome.Remodeling of rat pulmonary artery induced by chronic smoking exposure.Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in micePeroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model.Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responsesDysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury. Protective role of peroxisome proliferator-activated receptor-γ.Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus.PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.Airway epithelial cell PPARγ modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice.Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivoPostnatal rosiglitazone administration to neonatal rat pups does not alter the young adult metabolic phenotype.PPARs in alveolar macrophage biology.Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failureRole of PPARγ in COX-2 activation in mycobacterial pulmonary inflammation.Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages.Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?Stimulatory Effects of Peroxisome Proliferator-Activated Receptor-gamma on Fcgamma Receptor-Mediated Phagocytosis by Alveolar Macrophages.Peroxisome proliferator-activated receptors in lung cancer.Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthmaRegulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer.Thiazolidinediones as anti-cancer agents.Macrophages in tuberculosis: friend or foe.Simvastatin and a plant galactolipid protect animals from septic shock by regulating oxylipin mediator dynamics through the MAPK-cPLA2 signaling pathway.MUC1 mucin: a peacemaker in the lung.Diabetes, insulin, and development of acute lung injury.Regulation of the mucosal phenotype in dendritic cells by PPARγ: role of tissue microenvironment.Phagocytic clearance of apoptotic cells: role in lung diseasePPAR Agonists for the Prevention and Treatment of Lung Cancer.Challenges of treating asthma in people who smoke.Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.
P2860
Q28575608-FD920530-C8F2-4202-B4E3-FE9289CA685EQ33555078-2F5B5626-58E0-4EBE-A97A-42375E06C860Q33814581-7A6F2DA6-827D-4659-BBC7-F57EB6F89656Q34032853-809478B6-E74F-42CD-9C50-DACE27A17C49Q34064187-5F46B25E-06A9-4768-8AF7-14D7E31BCEEBQ34335599-C85B1C53-D260-411D-B610-BB1A5B0ABA6BQ34364700-BAAA5394-8F21-4ED2-A0C2-EAD90BDD7591Q34459867-72A23D8F-3A6E-45DE-8A42-C1CAD216AA59Q34480264-BE70801F-C13E-42C2-83DB-8A5A66C1E110Q34489192-C5B6E165-6C45-4F48-8EC0-E52D5A24D68DQ35190607-3589AA9F-4AC3-4437-85FC-395BCF386519Q35216293-F0BFFB8C-BE60-42E6-80CD-677AFB862459Q35760657-3988A32D-84A7-4FEE-9A4F-F4720570599CQ35916876-0B992C64-7FF3-4408-80F7-367479C7AF2DQ36053108-87956F4E-9ABD-4291-8124-49D6505993BAQ36072086-EC9723D2-9691-4094-A54B-5F1FA08AE3F1Q36121727-ECECBDDE-4AA6-4498-9146-F443220A22C2Q36224015-BB8352F8-2705-4663-A906-72B106825950Q36230193-B42D2EDB-762E-4B7D-B054-2DBFCD8EE2D7Q36312347-00C3CBEA-4E2E-4CAA-8819-ABFFC4395583Q36325488-20ADBD74-A2B7-4639-9849-6BBD81C8C2D0Q36417564-DCA968A7-D1C2-46FF-98EF-7C017E350354Q36417658-84B20A9D-7C4E-4C66-8F1A-4A6C2D83A468Q36440045-44DC74D4-C38E-4307-90F2-EB98EEC4C062Q36591722-05750070-84A6-41BC-8453-39085D62B227Q36605155-CFFCC37C-024F-4261-92B1-CAC78EF1A75AQ36687379-929F5700-5DC3-488D-A470-D2C0CC041A02Q36716822-0E031BF5-94D7-46C5-B909-160BBC6CE7E7Q36724871-65D7A4C1-7DBE-4D6C-BEF2-3FC77FB1C493Q36747305-89C9BF8D-16E7-41A5-855E-CBDAFD37EB65Q37010188-7B0EE4EE-046F-44A4-95E2-3D6EED9EDA57Q37147624-DC2D0049-0E65-4568-9F88-FEDE356596CFQ37170481-23E60DCA-C29B-43FD-A7CA-CE252AD410A1Q37212643-29C49C01-0263-44CC-BF32-926D1B98BB78Q37521491-EE096079-DB3C-49C5-B6E9-311FB9FABE97Q37581433-9BF3A0A4-6DB8-491E-9395-50B36E2F5860Q37640810-E2D110BB-68F6-476D-B42F-B014F3C86407Q37681630-10EFB190-8837-45B7-B374-A52ABB8C1AF2Q37733518-D856C094-F2AC-4975-8D62-D6621DDAD94EQ37847515-FD22DCAE-0720-4366-92F2-C827A6DF3127
P2860
Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... lung inflammation and repair.
@ast
Peroxisome proliferator-activa ...... lung inflammation and repair.
@en
type
label
Peroxisome proliferator-activa ...... lung inflammation and repair.
@ast
Peroxisome proliferator-activa ...... lung inflammation and repair.
@en
prefLabel
Peroxisome proliferator-activa ...... lung inflammation and repair.
@ast
Peroxisome proliferator-activa ...... lung inflammation and repair.
@en
P1476
Peroxisome proliferator-activa ...... f lung inflammation and repair
@en
P2093
Raju C Reddy
Theodore J Standiford
P304
P356
10.1513/PATS.200501-010AC
P577
2005-01-01T00:00:00Z